Apolipoprotein A1 in cerebrospinal fluid and plasma and progression to Alzheimer’s disease in non-demented elderly

Manuscript Number: 

15-1068R2

Author(s): 
Femke H. Bouwman, Wesley Jongbloed, Maartje I. Kester, Philip Scheltens, Rosalinde E.R. Slot, Charlotte E. Teunissen, Robert Veerhuis, Argonde van Harten, Wiesje M. van der Flier

Disclosures

Femke H. Bouwman

  • Patents/Royalties
    I perform presentations for GE Healthcare about 3 times a year

Wesley Jongbloed

  • Nothing to Disclose

Maartje I. Kester

  • Nothing to Disclose

Philip Scheltens

  • Nothing to Disclose

Rosalinde E.R. Slot

  • Nothing to Disclose

Charlotte E. Teunissen

  • Consulting Fees:
    Dr. Teunissen serves on the advisory board of Fujirebio and Roche

Wiesje M. van der Flier

  • Nothing to Disclose

Argonde van Harten

  • Nothing to Disclose

Robert Veerhuis

  • Nothing to Disclose